EP2603083A4 - Bismuth-thiols utilisables comme antiseptiques en agriculture, dans l'industrie et dans d'autres domaines - Google Patents

Bismuth-thiols utilisables comme antiseptiques en agriculture, dans l'industrie et dans d'autres domaines

Info

Publication number
EP2603083A4
EP2603083A4 EP11817067.9A EP11817067A EP2603083A4 EP 2603083 A4 EP2603083 A4 EP 2603083A4 EP 11817067 A EP11817067 A EP 11817067A EP 2603083 A4 EP2603083 A4 EP 2603083A4
Authority
EP
European Patent Office
Prior art keywords
antiseptics
thiols
bismuth
agricultural
industrial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11817067.9A
Other languages
German (de)
English (en)
Other versions
EP2603083A2 (fr
Inventor
Brett Hugh James Baker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbion Corp
Original Assignee
Microbion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/023549 external-priority patent/WO2011097347A2/fr
Application filed by Microbion Corp filed Critical Microbion Corp
Publication of EP2603083A2 publication Critical patent/EP2603083A2/fr
Publication of EP2603083A4 publication Critical patent/EP2603083A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
    • A01N55/02—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing metal atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/82—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Physiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
EP11817067.9A 2010-08-12 2011-08-11 Bismuth-thiols utilisables comme antiseptiques en agriculture, dans l'industrie et dans d'autres domaines Withdrawn EP2603083A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37318810P 2010-08-12 2010-08-12
PCT/US2011/023549 WO2011097347A2 (fr) 2010-02-03 2011-02-03 Bismuth-thiols comme antiseptiques destinés à des utilisations biomédicales, comprenant le traitement de biofilms bactériens et d'autres utilisations
PCT/US2011/047490 WO2012021754A2 (fr) 2010-08-12 2011-08-11 Bismuth-thiols utilisables comme antiseptiques en agriculture, dans l'industrie et dans d'autres domaines

Publications (2)

Publication Number Publication Date
EP2603083A2 EP2603083A2 (fr) 2013-06-19
EP2603083A4 true EP2603083A4 (fr) 2014-10-22

Family

ID=44356067

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11817067.9A Withdrawn EP2603083A4 (fr) 2010-08-12 2011-08-11 Bismuth-thiols utilisables comme antiseptiques en agriculture, dans l'industrie et dans d'autres domaines

Country Status (16)

Country Link
EP (1) EP2603083A4 (fr)
JP (7) JP2013535506A (fr)
KR (6) KR20200015814A (fr)
CN (2) CN103096720B (fr)
AU (3) AU2011289338B2 (fr)
BR (2) BR112012019286A2 (fr)
CA (1) CA2807993C (fr)
CL (2) CL2013000430A1 (fr)
IL (3) IL224684A (fr)
MX (4) MX371047B (fr)
NZ (1) NZ606634A (fr)
PH (1) PH12016502498A1 (fr)
RU (2) RU2018108411A (fr)
SG (3) SG10202001032RA (fr)
UA (1) UA113616C2 (fr)
WO (1) WO2012021754A2 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1007885A2 (pt) 2009-02-03 2016-02-16 Microbion Corp bismuto-tóis antissépticos para tecidos epiteliais, feridas agudas e crônicas, biofilmes bacterianos e outras indicações
US9028878B2 (en) 2009-02-03 2015-05-12 Microbion Corporation Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
BR112012019286A2 (pt) * 2010-02-03 2018-06-26 Microbion Corp bismuto-tióis como antisséptico para usos biomédicos, que incluem tratamento de biofilmes bacterianos e outros usos
ES2647499T3 (es) * 2013-03-18 2017-12-21 Theranovis Gmbh & Co. Kg Composición para el cuidado bucal
RU2525200C1 (ru) * 2013-04-09 2014-08-10 Алексей Георгиевич Бородкин Средство для защиты и заживления ран деревьев
KR101703732B1 (ko) * 2013-11-07 2017-02-07 (주)아모레퍼시픽 효소처리 동백나무 씨 오일을 포함하는 항염 조성물
WO2017145142A1 (fr) 2016-02-25 2017-08-31 Nobio Ltd. Compositions de microparticules et de nanoparticules comprenant des groupes à activité antimicrobienne
CN116725879A (zh) 2017-08-30 2023-09-12 诺比奥有限公司 抗微生物颗粒及其使用方法
CN107950536A (zh) * 2017-12-04 2018-04-24 刘志伟 一种含百菌清的杀菌组合物
CN108839186B (zh) * 2018-05-15 2021-02-26 阜南县金威工艺品有限公司 一种桑枝编织品防霉处理方法
MX2021001276A (es) 2018-07-31 2021-07-15 Microbion Corp Composiciones de bismuto-tiol y metodos para tratar heridas.
EP3829307A4 (fr) 2018-07-31 2022-08-03 Microbion Corporation Compositions de bismuth-thiol et méthodes d'utilisation
KR101990253B1 (ko) * 2018-11-22 2019-06-17 하봉호 컨테이너형 버섯재배장치
CN109997856B (zh) * 2019-04-15 2020-11-03 广西大学 一种小分子化合物的组合物及其应用
KR102126721B1 (ko) * 2019-07-16 2020-06-25 (주)인트론바이오테크놀로지 신규한 엔테로박터 애로진스 박테리오파지 Ent-AEP-1 및 이의 엔테로박터 애로진스 균과 엔테로박터 클로아카 균 증식 억제 용도
JP7458622B2 (ja) * 2019-09-18 2024-04-01 学校法人東京農業大学 抗生物質耐性微生物の耐性を低下させる物質及び抗生物質耐性微生物の耐性を低下させる方法
CN110663672B (zh) * 2019-11-13 2024-04-26 南京林业大学 一种螺纹驱动的根部施药头
US11479655B2 (en) * 2020-01-15 2022-10-25 The Boeing Company Compositions for use with polysulfide sealants and related methods
KR102197719B1 (ko) 2020-05-07 2021-01-04 곽태진 갑오징어 양식 시스템
CN111856546B (zh) * 2020-06-23 2022-07-29 中国辐射防护研究院 一种关于海洋生物灰中Cs-137放化分析的制样方法
CN113969300A (zh) * 2020-07-23 2022-01-25 启迪禾美生物科技(嘉兴)有限公司 一种桉树叶复合活性提取物工艺及其抗菌应用
CN112640907B (zh) * 2021-01-19 2021-11-16 西南大学 硫辛酸抑制植物真菌致病菌的新用途及防治柑橘果实采后真菌病害的方法
KR102431000B1 (ko) * 2021-07-22 2022-08-11 농업회사법인 주식회사 아그로비즈 아스피린과 벤조치아졸이 포함된 식물의 자가면역 증강제 조성물 및 이를 이용한 이용방법
EP4310192A1 (fr) * 2022-07-21 2024-01-24 C4Diagnostics Procédé de détermination de l'existence et/ou du degré de résistance de micro-organismes aux agents antimicrobiens
CN115323778B (zh) * 2022-08-16 2023-07-18 汕头市润丰纺织科技实业有限公司 壳聚糖-i型胶原氨基酸复合抗菌整理液及其制备方法和抗菌面料
TR2022012983A2 (tr) * 2022-08-17 2022-09-21 Marmara Ueniv Strateji Gelis Dai Bsk Muhasebe Birimi Kemi̇k rahatsizliklari ve/veya kirilmalari i̇çi̇n onarici ve tedavi̇ edi̇ci̇ özelli̇kte bi̇youyumlu bi̇r ürün ve söz konusu ürünün eldesi̇ i̇çi̇n bi̇r yöntem
CN115532295B (zh) * 2022-09-27 2023-07-25 苏州大学 含有Zn-N-C活性中心的纳米材料在去除细菌生物膜中的应用
KR102644907B1 (ko) * 2023-12-01 2024-03-07 (주)신용이엔씨 지반 보강을 위한 친환경 그라우팅용 조성물 및 이의 제조 방법

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2809971A (en) * 1955-11-22 1957-10-15 Olin Mathieson Heavy-metal derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same
US5928671A (en) * 1995-04-25 1999-07-27 Winthrop University Hospital Method and composition for inhibiting bacteria
US6086921A (en) * 1995-04-25 2000-07-11 Wintrop-University Hospital Metal/thiol biocides
US20020136780A1 (en) * 2001-01-22 2002-09-26 Batarseh Kareem I. Microbicidal composition containing potassium sodium tartrate
US20020197282A1 (en) * 1999-02-23 2002-12-26 Mohseni Saeed H. Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles
JP2004137241A (ja) * 2002-10-21 2004-05-13 Catalysts & Chem Ind Co Ltd 抗菌・防黴・防藻性組成物
AU2003204105B2 (en) * 1997-10-28 2005-11-17 Winthrop-University Hospital Metal/Thiol Biocides
WO2008092011A2 (fr) * 2007-01-24 2008-07-31 Cook Incorporated Produits médicaux inhibiteurs de pellicules biologiques
US20080292673A1 (en) * 2007-05-18 2008-11-27 Crudden Joseph J Bioactive agrichemical compositions and use therreof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3813644B2 (ja) * 1994-08-29 2006-08-23 英治 安里 ビスマス錯体およびそれを含有する抗菌剤
US6017936A (en) * 1997-03-14 2000-01-25 Arch Chemicals, Inc. Method for producing particles of pyrithione salts and particles so produced
US5999828A (en) * 1997-03-19 1999-12-07 Qualcomm Incorporated Multi-user wireless telephone having dual echo cancellers
AU2656799A (en) * 1998-02-04 1999-08-23 Winthrop-University Hospital Metal-thiols as imminomodulating agents
US6465015B1 (en) * 1998-02-24 2002-10-15 Arch Chemicals, Inc. Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles
TWI245763B (en) * 1998-04-02 2005-12-21 Janssen Pharmaceutica Nv Biocidal benzylbiphenyl derivatives
WO2000016623A1 (fr) * 1998-09-23 2000-03-30 Phycogen, Inc. Agents antisalissures
US6582719B2 (en) * 2001-02-02 2003-06-24 The Trustees Of Columbia University In The City Of New York Combinations of antiseptic and antibiotic agents that inhibit the development of resistant microorganisms
US7381751B2 (en) * 2003-08-26 2008-06-03 Shantha Sarangapani Antimicrobial composition for medical articles
KR101153785B1 (ko) * 2004-10-25 2012-07-09 셀로노바 바이오사이언시스 저머니 게엠베하 치료 및/또는 진단용으로 부가할 수 있는 중합체 입자 및이의 제조 및 사용 방법
JP4568232B2 (ja) * 2006-01-06 2010-10-27 秀和 西松 人工骨頭保持具
JP2007332040A (ja) * 2006-06-12 2007-12-27 Shinshu Univ カーボンナノチューブを含む抗菌剤とそれを用いた材料及び製剤
US20110008402A1 (en) * 2006-10-13 2011-01-13 Kane Biotech Inc. Souluble b-n-acetylglucoseaminidase based antibiofilm compositions and uses thereof
US8343536B2 (en) * 2007-01-25 2013-01-01 Cook Biotech Incorporated Biofilm-inhibiting medical products
WO2008150375A1 (fr) * 2007-06-01 2008-12-11 Arrow International, Inc. Cathéter à action fibrinolytique et antimicrobienne combinée et utilisations de celui-ci
BRPI0721916A2 (pt) * 2007-07-25 2015-05-05 Celonova Biosciences Inc Partículas poliméricas codificadas por cor e dimensionadas para aplicações terapêuticas e/ou diagnósticas e métodos de preparação e uso das mesmas
BRPI1007885A2 (pt) * 2009-02-03 2016-02-16 Microbion Corp bismuto-tóis antissépticos para tecidos epiteliais, feridas agudas e crônicas, biofilmes bacterianos e outras indicações
BR112012019286A2 (pt) 2010-02-03 2018-06-26 Microbion Corp bismuto-tióis como antisséptico para usos biomédicos, que incluem tratamento de biofilmes bacterianos e outros usos

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2809971A (en) * 1955-11-22 1957-10-15 Olin Mathieson Heavy-metal derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same
US5928671A (en) * 1995-04-25 1999-07-27 Winthrop University Hospital Method and composition for inhibiting bacteria
US6086921A (en) * 1995-04-25 2000-07-11 Wintrop-University Hospital Metal/thiol biocides
AU2003204105B2 (en) * 1997-10-28 2005-11-17 Winthrop-University Hospital Metal/Thiol Biocides
US20020197282A1 (en) * 1999-02-23 2002-12-26 Mohseni Saeed H. Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles
US20020136780A1 (en) * 2001-01-22 2002-09-26 Batarseh Kareem I. Microbicidal composition containing potassium sodium tartrate
JP2004137241A (ja) * 2002-10-21 2004-05-13 Catalysts & Chem Ind Co Ltd 抗菌・防黴・防藻性組成物
WO2008092011A2 (fr) * 2007-01-24 2008-07-31 Cook Incorporated Produits médicaux inhibiteurs de pellicules biologiques
US20080292673A1 (en) * 2007-05-18 2008-11-27 Crudden Joseph J Bioactive agrichemical compositions and use therreof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Derwent World Patents Index; AN 2004-369133, XP002728841 *
DOMENICO P ET AL: "Enhancement of Bismuth Antibacterila Activity with Lipophilic Thiol Chelators", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 41, no. 8, 1 August 1997 (1997-08-01), pages 1697 - 1703, XP002262341, ISSN: 0066-4804 *
LEE ET AL: "Inhibition of methicillin-resistant Staphylococcus aureaus biofilm formation with bismuth-thiol compounds", ABSTRACTS OF THE GENERAL MEETING OF THE AMERICAN SOCIETY FOR MICROBIOLOGY, THE SOCIETY WASHINGTON, DC, US, vol. 104, 1 January 2004 (2004-01-01), pages 111, XP009160853 *
See also references of WO2012021754A2 *
WILFREDO G VELOIRA ET AL: "In vitro activity and synergy of bismuth thiols and tobramycin against Burkholderia Cpacia complex", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, OXFORD UNIVERSITY PRESS, GB, vol. 52, no. 6, 1 December 2003 (2003-12-01), pages 915 - 919, XP008154593, ISSN: 0305-7453, [retrieved on 20031029], DOI: 10.1093/JAC/DKG471 *

Also Published As

Publication number Publication date
CN103096720B (zh) 2016-03-30
AU2011289338A1 (en) 2013-03-28
JP2016117741A (ja) 2016-06-30
AU2011289338B2 (en) 2015-01-22
CA2807993A1 (fr) 2012-02-16
KR101821833B1 (ko) 2018-01-25
KR20130000386A (ko) 2013-01-02
UA113616C2 (xx) 2017-02-27
BR112013003127A2 (pt) 2016-06-28
CL2017002549A1 (es) 2018-05-11
MX362785B (es) 2019-02-12
EP2603083A2 (fr) 2013-06-19
CN105766990B (zh) 2019-08-02
KR101966867B1 (ko) 2019-04-08
JP6685991B2 (ja) 2020-04-22
KR102074444B1 (ko) 2020-02-06
JP2020063277A (ja) 2020-04-23
JP2022003090A (ja) 2022-01-11
AU2018204190B2 (en) 2020-07-23
SG10201506131RA (en) 2015-09-29
KR20190039607A (ko) 2019-04-12
AU2016203475A1 (en) 2016-06-16
CL2013000430A1 (es) 2013-10-04
WO2012021754A3 (fr) 2012-05-24
BR112012019286A2 (pt) 2018-06-26
CA2807993C (fr) 2023-03-14
JP2018076358A (ja) 2018-05-17
JP2020055839A (ja) 2020-04-09
CN103096720A (zh) 2013-05-08
JP7097344B2 (ja) 2022-07-07
MX2019001293A (es) 2019-07-04
AU2018204190A1 (en) 2018-07-05
KR20130132410A (ko) 2013-12-04
SG187801A1 (en) 2013-03-28
RU2018108411A (ru) 2019-02-25
SG10202001032RA (en) 2020-04-29
NZ606634A (en) 2015-01-30
WO2012021754A2 (fr) 2012-02-16
RU2013110493A (ru) 2014-09-20
IL258908A (en) 2018-06-28
JP2018008971A (ja) 2018-01-18
MX371047B (es) 2020-01-14
JP2013535506A (ja) 2013-09-12
MX2013001581A (es) 2013-03-20
CN105766990A (zh) 2016-07-20
JP6272366B2 (ja) 2018-01-31
IL224684A (en) 2016-11-30
MX2019010863A (es) 2019-11-05
IL248446B (en) 2018-05-31
PH12016502498A1 (en) 2018-06-11
KR20180085042A (ko) 2018-07-25
KR20170136009A (ko) 2017-12-08
KR20200015814A (ko) 2020-02-12

Similar Documents

Publication Publication Date Title
IL258908A (en) Bismam thiols as disinfectants for use in agriculture, industry and other uses
ZA202002470B (en) Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
IL225926A (en) Boronate compounds, preparations containing them and their uses
ZA201205788B (en) 1,2,4-triazine-4-amine derivatives
HK1225308A1 (zh) 5-氯代-4-羥基-1-甲基-2-氧代基-n-苯基-1，2-二氫喹啉-3-甲酰胺，其鹽和用法
IL259652B (en) A bacterial strain, a preparation containing it and its uses
IL223405B (en) Phosphoplatins, preparations containing them and their uses
GB201011801D0 (en) Anti-microbial products
ZA201208275B (en) Chitosan composition
ZA201304016B (en) Photochromic compounds, compositions and articles
SG10201503504VA (en) Novel Antimicrobial Compounds And Uses Thereof
MY165626A (en) 1,2,4,-triazolone derivative
IL225440A0 (en) Compounds of cyclohexane derivatives, preparations containing them and their uses
IL225724A (en) History of acylbenzene, its salts and their uses
EP2653606A4 (fr) Agent de traitement de fibres
EP2544542A4 (fr) Composés analgésiques, compositions en contenant et leurs utilisations
AP2011005724A0 (en) Agricultural implement.
AU2010900179A0 (en) Flink Link
GB201010608D0 (en) Compounds, compositions and use
AU2010902529A0 (en) Improved Pruner
AP2011005645A0 (en) Parasiticidal formulation.
AU2010900721A0 (en) Insecticidal composition
AU2010901109A0 (en) Adjustable, multi-purpose plus

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130305

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20140922

RIC1 Information provided on ipc code assigned before grant

Ipc: A01P 1/00 20060101ALI20140916BHEP

Ipc: A01N 55/02 20060101AFI20140916BHEP

17Q First examination report despatched

Effective date: 20161006

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200808